Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AE01	CAPTAIN	G	Ibuprofen - 200mg	200mg	Capsule, soft gelatin	383,955 L.L
R06AE09	CALIVIDA	G	Levocetirizine dihydrochloride - 0.5mg/ml	0.5mg/ml	Solution	1,158,264 L.L
C10AA07	CRESULIP 10	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	575,933 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacin - 200mg/100ml	200mg/100ml	Injectable solution	4,914,432 L.L
J01MA02	CIPROLON 200	G	Ciprofloxacin (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	686,704 L.L
J01MA02	CIPROX	G	Ciprofloxacine (lactate) - 200mg/100ml	0.2%w/v	Injectable solution	520,067 L.L
M01AE01	CAPTAIN	G	Ibuprofen - 100mg/5ml	100mg/5ml	Suspension	335,321 L.L
J01MA02	CEFLOXINE	G	Ciprofloxacin - 400mg/200ml	400mg/200ml	Injectable solution	1,134,203 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	629,916 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 400mg/200ml	400mg/200ml (2mg/ml)	Injectable solution	9,908,924 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	769,337 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 400mg/200ml	400mg/200ml	Injectable solution	9,908,924 L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l		Injectable solution	735,741 L.L
B05D	CAPD/DPCA 3Solution for peritoneal dialysis	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 42.50g/l, Glucose monohydrate - 46.75g/l		Injectable solution	769,337 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 8mg	8mg	Tablet, scored	434,061 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	744,140 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	744,140 L.L
J01DB04	CEFAZOLIN PANPHARMA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	5,521,849 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
J01DB04	CEFAZOLINA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	18,574,396 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 16mg	16mg	Tablet, scored	434,061 L.L
C10AA07	CONSIVAS 20	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	450,187 L.L
J01DB05	CEFADRIL	G	Cefadroxil (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	268,769 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 32mg	32mg	Tablet, scored	434,061 L.L
C10AA07	CRESOTAB	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	517,379 L.L
C10AA07	CRESULIP 20	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet, film coated	575,933 L.L
R06AX13	CLARA	G	Loratadine (micronised) - 10mg	10mg	Tablet	131,697 L.L
M01AE01	CAPTAIN FORTE	G	Ibuprofen - 400mg	400mg	Capsule, soft gelatin	508,740 L.L

...